David Allan
Directeur/Membre du Conseil chez Life Sciences Ontario
Profil
David G.
P.
Allan is the founder of Knowledge Based Industries Group (1992).
He held the title of Executive Director during the founding year.
Mr. Allan's current jobs are Director at Life Sciences Ontario, Trustee at OCAD University, and Principal at Cresswell Advisors, Inc. (since 1995).
Mr. Allan's former jobs include Chairman & Chief Executive Officer at YM BioSciences, Inc. (1994-2012), Chairman at Trillium Therapeutics ULC (2011-2014), Chairman at YM Biosciences USA, Inc. (1998-2011), Director at SyntheMed, Inc. (2003-2010), Independent Director at DiaMedica Therapeutics, Inc. (2010-2013), Executive Director at Orion Securities, Inc. (1992-1998), Independent Director at Avivagen, Inc. (2015-2016), Director at Shaw Festival Theatre, Director at Loewen, Ondaatje, McCutcheon Ltd.
(1987-1992), Director at Bristol-Myers Squibb FCT bêta, Inc., Governor at Toronto Stock Exchange, Inc., and Member-Awards Selection Committee at Networks of Centres of Excellence.
Postes actifs de David Allan
| Sociétés | Poste | Début |
|---|---|---|
| Life Sciences Ontario | Directeur/Membre du Conseil | - |
| OCAD University | Directeur/Membre du Conseil | - |
Cresswell Advisors, Inc.
 Cresswell Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Cresswell Advisors, Inc. provides assistance and direction to development-stage companies in the life sciences and for earlier-stage companies in multiple fields. It also offers strategic advisory, negotiation and completion, project management, business development, regulatory compliance, corporate governance, financing strategies, and recruitment services. The company was founded in 1981 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01/01/1995 |
Anciens postes connus de David Allan
| Sociétés | Poste | Fin |
|---|---|---|
| AVIVAGEN INC. | Directeur/Membre du Conseil | 27/10/2016 |
| TRILLIUM THERAPEUTICS | Directeur Général | 20/01/2014 |
| DIAMEDICA THERAPEUTICS INC. | Directeur/Membre du Conseil | 22/02/2013 |
YM Biosciences USA, Inc.
 YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Président | 01/02/2011 |
SyntheMed, Inc.
 SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Directeur/Membre du Conseil | 16/09/2011 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DIAMEDICA THERAPEUTICS INC. | Health Technology |
| AVIVAGEN INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
Orion Securities, Inc.
 Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | Finance |
Toronto Stock Exchange, Inc.
 Toronto Stock Exchange, Inc. Investment Banks/BrokersFinance Toronto Stock Exchange operates as a stock exchange. It provides opportunities to access public equity capital, liquidity for existing investors, and monitor market exposure associated with Canada's senior exchange. Toronto Stock Exchange was founded in 1852 and is located in Toronto, ON. | Finance |
Shaw Festival Theatre
 Shaw Festival Theatre Movies/EntertainmentConsumer Services Shaw Festival Theatre operates as a non profit organization that engages in performing art theatres. The company was founded by Brian Doherty in 1962 and is headquartered in Niagara-on-the-Lake, Canada. | Consumer Services |
YM Biosciences USA, Inc.
YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Health Technology |
Loewen, Ondaatje, McCutcheon Ltd.
 Loewen, Ondaatje, McCutcheon Ltd. Investment Banks/BrokersFinance Loewen, Ondaatje, McCutcheon Ltd. (LOM) is an independent Canadian broker/dealer firm headquartered in Toronto, Ontario. Founded in 1970, the firm combines objective research and value-added financing ideas with institutional sales, trading and investment banking. They are a provider of value-added North American research. LOM focuses exclusively on advising small and mid-cap companies, with a strong focus on select emerging growth companies in industries that include Technology, Healthcare, and Mining. | Finance |
Networks of Centres of Excellence
 Networks of Centres of Excellence Miscellaneous Commercial ServicesCommercial Services Networks of Centres of Excellence offers programs that focuses on research and development. The company was founded in 1989 and is headquartered in Ontario, Canada. | Commercial Services |
| Knowledge Based Industries Group | |
| Life Sciences Ontario | |
Cresswell Advisors, Inc.
Cresswell Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Cresswell Advisors, Inc. provides assistance and direction to development-stage companies in the life sciences and for earlier-stage companies in multiple fields. It also offers strategic advisory, negotiation and completion, project management, business development, regulatory compliance, corporate governance, financing strategies, and recruitment services. The company was founded in 1981 and is headquartered in Toronto, Canada. | Commercial Services |
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Health Technology |